190
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Acriflavine-loaded solid lipid nanoparticles: preparation, physicochemical characterization, and anti-proliferative properties

, , , & ORCID Icon
Pages 934-942 | Received 17 Dec 2020, Accepted 29 Jul 2021, Published online: 25 Aug 2021

References

  • Azzopardi M, Farrugia G, Balzan R. 2017. Cell-cycle involvement in autophagy and apoptosis in yeast. Mech Ageing Dev. 161(Pt B):211–224.
  • Bahadori MB, Eskandani M, De Mieri M, Hamburger M, Nazemiyeh H. 2018. Anti-proliferative activity-guided isolation of clerodermic acid from Salvia nemorosa L.: geno/cytotoxicity and hypoxia-mediated mechanism of action. Food Chem Toxicol. 120:155–163.
  • Bahadori MB, Vandghanooni S, Dinparast L, Eskandani M, Ayatollahi SA, Ata A, Nazemiyeh H. 2019. Triterpenoid corosolic acid attenuates HIF-1 stabilization upon cobalt (II) chloride-induced hypoxia in A549 human lung epithelial cancer cells. Fitoterapia. 134:493–500.
  • Bai M, Papoudou-Bai A, Kitsoulis P, Horianopoulos N, Kamina S, Agnantis NJ, Kanavaros P. 2005. Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas. In Vivo. 19(2):439–454.
  • Bortner CD, Oldenburg NB, Cidlowski JA. 1995. The role of DNA fragmentation in apoptosis. Trends Cell Biol. 5(1):21–26.
  • Bossy-Wetzel E, Green DR. 2000. Detection of apoptosis by annexin V labeling. Methods Enzymol. 322:15–18.
  • Bõsze P. 2007. Cell cycle and apoptosis as they pertain to chemotherapy. CME. 12:3–11.
  • Chan-Curtis V, Belt WD, Ladoulis CT. 1970. Cytochemical localization of nucleic acids by an acriflavine-phosphotungstate complex for fluorescence microscopy and electron microscopy. J Histochem Cytochem. 18(9):609–627.
  • Debatin K-M. 2017. Cell death: from initial concepts to pathways to clinical applications – personal reflections of a clinical researcher. Biochem Biophys Res Commun. 482(3):445–449.
  • Dekervel J, Bulle A, Windmolders P, Lambrechts D, Van Cutsem E, Verslype C, van Pelt J. 2017. Acriflavine inhibits acquired drug resistance by blocking the epithelial-to-mesenchymal transition and the unfolded protein response. Transl Oncol. 10(1):59–69.
  • Eskandani M, Barar J, Dolatabadi JEN, Hamishehkar H, Nazemiyeh H. 2015. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles. Pharm Biol. 53(10):1525–1538.
  • Eskandani M, Hamishehkar H, Dolatabadi JEN. 2013. Cyto/genotoxicity study of polyoxyethylene (20) sorbitan monolaurate (tween 20). DNA Cell Biol. 32(9):498–503.
  • Eskandani M, Nazemiyeh H. 2014. Self-reporter shikonin-act-loaded solid lipid nanoparticle: Formulation, physicochemical characterization and geno/cytotoxicity evaluation. Eur J Pharm Sci. 59(1):49–57.
  • Esposito G, Tamby MC, Chanseaud Y, Servettaz A, Guillevin L, Mouthon L. 2005. Anti-annexin V antibodies: are they prothrombotic? Autoimmun Rev. 4(1):55–60.
  • Ezzati Nazhad Dolatabadi J, Hamishehkar H, Eskandani M, Valizadeh H. 2014. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 117:21–28.
  • Fan J, Yang X, Bi Z. 2014. Acriflavine suppresses the growth of human osteosarcoma cells through apoptosis and autophagy. Tumour Biol. 35(10):9571–9576.
  • González-Pardo V, Suares A, Verstuyf A, De Clercq P, Boland R, de Boland AR. 2014. Cell cycle arrest and apoptosis induced by 1α,25(OH)2D3 and TX 527 in Kaposi sarcoma is VDR dependent. J Steroid Biochem Mol Biol. 144 Pt A:197–200.
  • Hamishehkar H, Bahadori MB, Vandghanooni S, Eskandani M, Nakhlband A, Eskandani M. 2018. Preparation, characterization and anti-proliferative effects of sclareol-loaded solid lipid nanoparticles on A549 human lung epithelial cancer cells. J Drug Delivery Sci Technol. 45:272–280.
  • Hao J, Fang X, Zhou Y, Wang J, Guo F, Li F, Peng X. 2011. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomedicine. 6:683–692.
  • Hassan S, Laryea D, Mahteme H, Felth J, Fryknäs M, Fayad W, Linder S, Rickardson L, Gullbo J, Graf W, et al. 2011. Novel activity of acriflavine against colorectal cancer tumor cells. Cancer Sci. 102(12):2206–2213.
  • ICH-Q1A-(R2). 2003. Stability testing guidelines: stability testing of new drug substances and products. London: European Medicines Agency.
  • Khodarev NN, Sokolova IA, Vaughan ATM. 1998. Mechanisms of induction of apoptotic DNA fragmentation. Int J Radiat Biol. 73(5):455–467.
  • Lee C-J, Yue C-H, Lin Y-J, Lin Y-Y, Kao S-H, Liu J-Y, Chen Y-H. 2014. Antitumor activity of acriflavine in lung adenocarcinoma cell line A549. Anticancer Res. 34(11):6467–6472.
  • Lee K, Zhang H, Qian DZ, Rey S, Liu JO, Semenza GL. 2009. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci. 106(42):17910–17915.
  • Keyhani E, Khavari-Nejad S, Keyhani J, Attar F. 2009. Acriflavine-mediated apoptosis and necrosis in yeast Candida utilis. Ann N Y Acad Sci. 1171:284–291.
  • Nagata S, Tanaka M. 2017. Programmed cell death and the immune system. Nat Rev Immunol. 17(5):333–340.
  • Nakhlband A, Eskandani M, Saeedi N, Ghafari S, Omidi Y, Barar J, Garjani A. 2018. Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: a study for cardioprotective effect. Colloids Surf B Biointerfaces. 164:299–307.
  • Nazemiyeh E, Eskandani M, Sheikhloie H, Nazemiyeh H. 2016. Formulation and physicochemical characterization of lycopene-loaded solid lipid nanoparticles. Adv Pharm Bull. 6(2):235–241.
  • Niu G, Chen X. 2010. Apoptosis imaging: beyond annexin V. J Nucl Med. 51(11):1659–1662.
  • Paranjpe M, Müller-Goymann CC. 2014. Nanoparticle-mediated pulmonary drug delivery: a review. Int J Mol Sci. 15(4):5852–5873.
  • Pépin G, Nejad C, Thomas BJ, Ferrand J, McArthur K, Bardin PG, Williams BR, Gantier MP. 2017. Activation of cGAS-dependent antiviral responses by DNA intercalating agents. Nucleic Acids Res. 45(1):198–205.
  • Peppas NA, Sahlin JJ. 1989. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm. 57(2):169–172.
  • Salmanzadeh R, Eskandani M, Mokhtarzadeh A, Vandghanooni S, Ilghami R, Maleki H, Saeeidi N, Omidi Y. 2018. Propyl gallate (PG) and tert-butylhydroquinone (TBHQ) may alter the potential anti-cancer behavior of probiotics. Food Bioscience. 24:37–45.
  • Singh A, Worku ZA, Van Den Mooter G. 2011. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin Drug Deliv. 8(10):1361–1378.
  • Van Heerde WL, De Groot PG, Reutelingsperger CPM. 1995. The complexity of the phospholipid binding protein Annexin V. Thromb Haemost. 73(02):172–179.
  • Vandghanooni S, Eskandani M, Barar J, Omidi Y. 2018. AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells. Nanomed. 13(21):2729–2758.
  • Vandghanooni S, Eskandani M, Barar J, Omidi Y. 2020. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells. Int J Pharm. 573: 118729.
  • Venkateswarlu V, Manjunath K. 2004. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Controlled Release. 95(3):627–638.
  • Xie S, Pan B, Shi B, Zhang Z, Zhang X, Wang M, Zhou W. 2011. Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm. Int J Nanomedicine. 6:2367–2374.
  • Zamanlu M, Eskandani M, Barar J, Jaymand M, Pakchin PS, Farhoudi M. 2019. Enhanced thrombolysis using tissue plasminogen activator (tPA)-loaded PEGylated PLGA nanoparticles for ischemic stroke. J Drug Delivery Sci Technol. 53:101165.
  • Zhang J, Xu M. 2002. Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell Biol. 12(2):84–89.
  • Zhang JH, Xu M. 2000. DNA fragmentation in apoptosis. Cell Res. 10(3):205–211.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.